Molecular Diagnostics Market by Application (Infectious Disease (HIV, Hepatitis), Genetic Testing, Oncology), Product & Service (Reagent, Software), Technology (DNA Sequencing & NGS, PCR), End User (Academic/Hospital Laboratory) – 2023 to 2028

SKU: GMS1196

Format: PDF

Overall Rating
4.5/5

OVERVIEW

The market for molecular diagnostics is expected to reach USD 12.2 billion by 2024, growing over the forecast period at a CAGR of 8%. The rise in this market is driven primarily by the high prevalence of infectious diseases and various types of cancers, growing awareness and acceptance of personalized medicine and companion diagnostics, development in the market for biomarker detection, and advances in molecular techniques.

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 1

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 2

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 3

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 4

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 5

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 6

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 7

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 8

TABLE OF CONTENT

1 Global Molecular Diagnostics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Molecular Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Molecular Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Molecular Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Molecular Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Molecular Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Molecular Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments

9 Global Molecular Diagnostics Market – By Technology
9.1 In Situ Hybridization
9.2 Chips and Microarrays
9.3 Mass Spectrometry (MS)
9.4 Sequencing
9.5 PCR
9.6 Other

10 Global Molecular Diagnostics Market – By Application
10.1 Infectious Disease
10.2 Oncology
10.3 Pharmacogenomics
10.4 Microbiology
10.5 Genetic Disease Screening
10.6 Human Leukocyte Antigen Typing
10.7 Others

11 Global Molecular Diagnostics Market – By End-User
11.1 Hospital
11.2 Laboratories
11.3 Other

12 Global Molecular Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Molecular Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Molecular Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Agilent Technologies
14.3 Abbott Laboratories
14.4 Illumina
14.5 Danaher Corporation
14.6 Grifols
14.7 Becton, Dickinson and Company
14.8 Biomérieux Sa
14.9 Diasorin
14.10 Hologic
14.11 Qiagen
14.12 Company 11 & more

15 Global Molecular Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations

Share

Get A Free Sample

Take a look at this complimentary sample which comprises of a variety of market data points such as trend analyses, market estimates, and forecasts. You can explore and evaluate it on your own.

Send me Free Sample

Or View Our License Options:

$3,850.00$5,850.00

Why

Industry Coverage: Global Market Studies has a broad range of industry coverage, spanning various sectors such as healthcare, technology, retail, automotive, and many others. This means that clients can rely on us to provide valuable insights into their respective industries, helping them make informed business decisions.

Our team of experts has years of experience in the market research industry, and they have honed their skills in data analysis, market forecasting, and trend analysis. They are also adept at using advanced research tools and techniques to gather and analyze data, providing clients with accurate and reliable insights.

We understand that each client has unique research needs, and we tailor our research solutions to meet their specific requirements. We work closely with our clients to understand their objectives and provide customized research solutions that address their business challenges.

We are committed to innovation and are constantly exploring new research methods and techniques to provide our clients with cutting-edge insights. This enables us to stay ahead of the curve and deliver the best possible research outcomes.

At Global Market Studies, our clients are at the center of everything we do. We pride ourselves on providing excellent customer service and support, and we are always available to address our clients’ concerns and questions.

83422+ Reports Delivered

Accurate market data is crucial to a successful business strategy. With an 85% + accuracy in all reports, makes us one of the best and most accurate firms in the world.

Need Customized Report ?Call Now

OVERVIEW

The market for molecular diagnostics is expected to reach USD 12.2 billion by 2024, growing over the forecast period at a CAGR of 8%. The rise in this market is driven primarily by the high prevalence of infectious diseases and various types of cancers, growing awareness and acceptance of personalized medicine and companion diagnostics, development in the market for biomarker detection, and advances in molecular techniques.

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 9

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 10

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 11

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 12

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 13

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 14

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 15

Molecular diagnostics market by application (infectious disease (hiv, hepatitis), genetic testing, oncology), product & service (reagent, software), technology (dna sequencing & ngs, pcr), end user (academic/hospital laboratory) - 2023 to 2028 16

TABLE OF CONTENT

1 Global Molecular Diagnostics Market 
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Molecular Diagnostics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Molecular Diagnostics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Molecular Diagnostics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Molecular Diagnostics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Molecular Diagnostics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Molecular Diagnostics Market – By Product (Market Size – & million/billion)
8.1 Reagents & Kits
8.2 Instruments

9 Global Molecular Diagnostics Market – By Technology
9.1 In Situ Hybridization
9.2 Chips and Microarrays
9.3 Mass Spectrometry (MS)
9.4 Sequencing
9.5 PCR
9.6 Other

10 Global Molecular Diagnostics Market – By Application
10.1 Infectious Disease
10.2 Oncology
10.3 Pharmacogenomics
10.4 Microbiology
10.5 Genetic Disease Screening
10.6 Human Leukocyte Antigen Typing
10.7 Others

11 Global Molecular Diagnostics Market – By End-User
11.1 Hospital
11.2 Laboratories
11.3 Other

12 Global Molecular Diagnostics Market – By Geography (Market Size – & million/billion)
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 U.K
12.3.2 Germany
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia-Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 South Korea
12.4.5 Rest of APAC
12.5 Rest of the World
12.5.1 South America
12.5.2 Middle East
12.5.3 Africa

13 Global Molecular Diagnostics Market – Entropy
13.1 New product launches
13.2 M&A’s, collaborations, JVs and partnerships

14 Global Molecular Diagnostics Market Company Profile (Key Players)
14.1 Market Share, Company Revenue, Products, M&A, Developments
14.2 Agilent Technologies
14.3 Abbott Laboratories
14.4 Illumina
14.5 Danaher Corporation
14.6 Grifols
14.7 Becton, Dickinson and Company
14.8 Biomérieux Sa
14.9 Diasorin
14.10 Hologic
14.11 Qiagen
14.12 Company 11 & more

15 Global Molecular Diagnostics Market – Appendix
15.1 Sources
15.2 Abbreviations

Related Research Reports